Operating margin · 2019–2025
Bioventus operating margin
9.5%+12.2 pp · FY2025
Bioventus (BVS) reported 9.5% in operating margin for fiscal 2025, +12.2 pp from the year before.
| Fiscal year | Operating margin | Change | Filing |
|---|---|---|---|
| FY2025 | 9.5% | +12.2 pp | Derived |
| FY2024 | −2.7% | +13.3 pp | Derived |
| FY2023 | −16.0% | +16.7 pp | Derived |
| FY2022 | −32.7% | −35.5 pp | Derived |
| FY2021 | 2.8% | −57.7% | Derived |
| FY2020 | 6.6% | −27.9% | Derived |
| FY2019 | 9.2% | — | Derived |
Operating margin — Operating margin is operating income divided by revenue. Only companies with at least $1 billion in revenue are ranked here.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2019–2025 compound annual growth +0.6%
Calculated from two reported figures, so it has no single filing of its own.
Operating margin at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Bioventus operating margin |url=https://companiesranked.com/en/company/bioventus/operating-margin |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Bioventus operating margin. CompaniesRanked. https://companiesranked.com/en/company/bioventus/operating-marginBibTeX
@misc{companiesranked-en-company-bioventus-operating-margin-2026,
author = {{CompaniesRanked}},
title = {{Bioventus operating margin}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/bioventus/operating-margin}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.